Stay updated on Olaparib & Atezolizumab in BRCA+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Olaparib & Atezolizumab in BRCA+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Olaparib & Atezolizumab in BRCA+ Breast Cancer Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, replacing the study details with an access-denied notice. The error screen includes the standard site chrome and footer, indicating the content is not reachable in this view.
    Difference
    24%
    Check dated 2026-09-24T20:41:52.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The page revision label has been updated from v3.6.6 to v3.7.0, indicating a new revision of the page rather than a substantive change to the study details.
    Difference
    0.0%
    Check dated 2026-09-17T21:57:16.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    Enrollment updated to 89 participants, and key dates updated from estimated to actual: primary completion on 2026-06-10 and study completion on 2027-08-26, with the latest update posted on 2026-08-28.
    Difference
    0.3%
    Check dated 2026-09-03T19:55:59.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    UPMC Hillman Cancer Center was added as a Pittsburgh study site, and University of Pittsburgh Cancer Institute (UPCI) was removed from the listed locations.
    Difference
    0.1%
    Check dated 2026-08-06T16:39:51.000Z thumbnail image
  6. Check
    68 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.3 to v3.6.4. This reflects a new revision release of the Study Details page, likely including minor fixes or tweaks to metadata or content.
    Difference
    0.0%
    Check dated 2026-07-23T09:47:10.000Z thumbnail image
  7. Check
    89 days ago
    Change Detected
    Summary
    The page now displays revision v3.6.3, replacing the previous revision v3.6.1. This indicates a version update to the page, likely reflecting minor edits or corrections rather than substantive changes to study information.
    Difference
    0.0%
    Check dated 2026-07-02T02:24:04.000Z thumbnail image

Stay in the know with updates to Olaparib & Atezolizumab in BRCA+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Olaparib & Atezolizumab in BRCA+ Breast Cancer Clinical Trial page.